Interleukin-1 receptor antagonist anakinra as treatment for paradoxical responses in HIV-negative tuberculosis patients: A case series-Reference-Cited by-同舟云学术

Interleukin-1 receptor antagonist anakinra as treatment for paradoxical responses in HIV-negative tuberculosis patients: A case series

Published:2022-09 Issue:9 Volume:3 Page:603-611.e2
ISSN:2666-6340
Container-title:Med
language:en
Short-container-title:Med

Author:

van Arkel Cynthia^ORCID,Boeree Martin,Magis-Escurra Cécile,Hoefsloot Wouter,Carpaij Neeltje,van Ingen Jakko,Pegge Sjoert,Wielders Pascal,Smeenk Frank,Aarnoutse Rob,Netea Mihai G.,van Crevel Reinout,van Laarhoven Arjan

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

General Medicine

Reference17 articles.

1. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients;Geri;Infection,2013

2. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients;Cheng;Eur. J. Clin. Microbiol. Infect. Dis.,2002

3. Inflammasome activation underlying central nervous system deterioration in HIV-associated tuberculosis;Marais;J. Infect. Dis.,2017

4. HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling;Lai;Nat. Commun.,2015

5. Cerebral autoinflammatory disease treated with anakinra;Jang;Ann. Clin. Transl. Neurol.,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-tuberculosis treatment paradoxical reactions;Infection;2024-07-02

2. Severe osteoarticular and skin and soft tissue infection with Mycobacterium bovis following intravesical BCG instillation;Clinical Infection in Practice;2024-04

3. Advancing Diagnosis and Treatment in People Living with HIV and Tuberculosis Meningitis;Current HIV/AIDS Reports;2023-11-10

4. Current Insights into Diagnosing and Treating Neurotuberculosis in Adults;CNS Drugs;2023-11

5. Which trial do we need? A global, adaptive, platform trial to reduce death and disability from tuberculous meningitis;Clinical Microbiology and Infection;2023-07